| Serial Number | 77672421 |
| Word Mark | MONDORARE |
| Filing Date | Tuesday, February 17, 2009 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, March 16, 2018 |
| Registration Number | 4007941 |
| Registration Date | Tuesday, August 9, 2011 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 24, 2011 |
| Goods and Services | Pharmaceutical preparations for the treatment or prophylaxis of infectious diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of immunological diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of autoimmune diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of cardiovascular diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of inflammatory diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of neurodegenerative diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of neurological diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of psychiatric diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of otorhinolaryngologic diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of eye diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of dental diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of kidney diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of liver diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of gastrointestinal diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of metabolic diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of gynecological diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of andrological diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of urologic diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of geriatric diseases and states in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of orthopaedic diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of diseases of the bones and joints in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of muscular diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of skin diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of pain in humans or animals; pharmaceutical preparations for the treatment of and preparation to surgical states in humans or animals; pharmaceutical preparations for anaesthesia in humans or animals; pharmaceutical preparations for obstetrics or abortion in humans or animals; pharmaceutical preparations for cosmetic purposes in humans or animals; Pharmaceutical preparations for treating respiratory diseases and asthma; Pharmaceutical preparations for treatment of pulmonary diseases; Pharmaceutical preparations for the treatment of hypertension; Pharmaceutical preparations for use in the treatment of cancer; Pharmaceutical preparations for use in chemotherapy; Biological preparations for medical purposes; Biological preparations for veterinary purposes; Bronchodilating preparations; Veterinary preparations for the treatment of infectious diseases; Veterinary preparations for the treatment of non-infectious diseases; pharmaceutical preparations, namely, contrast agents for radiography, x-ray radiography, computer tomography, magnetic resonance imaging, magnetic resonance tomography, ultrasonography or positron emission tomography; Chemical preparations for medical purposes; Chemical preparations for pharmaceutical purposes; Chemical reagents for medical or veterinary purposes; Chemico-pharmaceutical preparations for the treatment or prophylaxis of infectious diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of immunological diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of autoimmune diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of cardiovascular diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of inflammatory diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of neurodegenerative diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of neurological diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of psychiatric diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of otorhinolaryngologic diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of eye diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of dental diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of kidney diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of liver diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of gastrointestinal diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of metabolic diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of gynecological diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of andrological diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of urologic diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of geriatric diseases and states in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of orthopaedic diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of diseases of the bones and joints in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of muscular diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of skin diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of pain in humans or animals; Chemico-pharmaceutical preparations for the treatment of and preparation to surgical states in humans or animals; Chemico-pharmaceutical preparations for anaesthesia in humans or animals; Chemico-pharmaceutical preparations for obstetrics or abortion in humans or animals; Chemico-pharmaceutical preparations for cosmetic purposes in humans or animals; Diagnostic preparations for clinical or medical use; Diagnostic preparations for veterinary use; Dietetic substances adapted for medical use; Disinfectants; Preparations for destroying vermin; Fungicides; Herbicides; Drugs for medical purposes; Medicines for the treatment or prophylaxis of dental diseases and states and dental cosmetic purposes; Medicines for the treatment or prophylaxis of infectious diseases in humans or animals; Medicines for the treatment or prophylaxis of immunological diseases in humans or animals; Medicines for the treatment or prophylaxis of autoimmune diseases in humans or animals; Medicines for the treatment or prophylaxis of cardiovascular diseases in humans or animals; Medicines for the treatment or prophylaxis of inflammatory diseases in humans or animals; Medicines for the treatment or prophylaxis of neurodegenerative diseases in humans or animals; Medicines for the treatment or prophylaxis of neurological diseases in humans or animals; Medicines for the treatment or prophylaxis of psychiatric diseases in humans or animals; Medicines for the treatment or prophylaxis of otorhinolaryngologic diseases in humans or animals; Medicines for the treatment or prophylaxis of eye diseases in humans or animals; Medicines for the treatment or prophylaxis of dental diseases in humans or animals; Medicines for the treatment or prophylaxis of kidney diseases in humans or animals; Medicines for the treatment or prophylaxis of liver diseases in humans or animals; Medicines for the treatment or prophylaxis of gastrointestinal diseases in humans or animals; Medicines for the treatment or prophylaxis of metabolic diseases in humans or animals; Medicines for the treatment or prophylaxis of gynecological diseases in humans or animals; Medicines for the treatment or prophylaxis of andrological diseases in humans or animals; Medicines for the treatment or prophylaxis of urologic diseases in humans or animals; Medicines for the treatment or prophylaxis of geriatric diseases and states in humans or animals; Medicines for the treatment or prophylaxis of orthopaedic diseases in humans or animals; Medicines for the treatment or prophylaxis of diseases of the bones and joints in humans or animals; Medicines for the treatment or prophylaxis of muscular diseases in humans or animals; Medicines for the treatment or prophylaxis of skin diseases in humans or animals; Medicines for the treatment or prophylaxis of pain in humans or animals; Medicines for the treatment of and preparation to surgical states in humans or animals; Medicines for anaesthesia in humans or animals; Medicines for obstetrics or abortion in humans or animals; Medicines for cosmetic purposes in humans or animals; Medical preparations for mouth care; Medical preparations for skin care; Sanitary preparations for medical use |
| Goods and Services | Business appraisals; Business consulting services for scientific projects in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Business information services for scientific projects in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Business inquiry services for scientific projects in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Business investigation services for scientific projects in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Business management and organization services for scientific projects in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Business management assistance services for scientific projects in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Business management consultancy services for scientific projects in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Business organization consultancy services for scientific projects in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Business acquisition and merger consultation in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Procurement of legal and technical know-how (franchising) in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Procurement of scientific cooperations in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Providing business consulting and management services for the commercialization of scientific projects in the field of medicine, pharmacy, biology, chemistry or medicine-technology |
| Goods and Services | Providing of training in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Arranging and conducting of colloquiums in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Arranging and conducting of conferences in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Arranging and conducting of congresses in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Arranging and conducting of seminars in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Arranging and conducting of symposiums in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Arranging and conducting of workshops training in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Correspondence courses in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Educational services, namely, providing courses of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Organization of exhibitions for cultural or educational purposes; Practical training demonstration in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology |
| Goods and Services | Biological research; Chemical analysis; Chemical Research; Chemistry services, namely, performing commissioned preparations, syntheses, patent search and literature search in the field of chemistry; Cosmetic research; Technical research in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry or medicine-technology; Project studies Technical in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry or medicine-technology; Medical and scientific development and research services in the field of medical, biochemical, pharmaceutical and medicine-technological research; Commissioned research and development work in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry or medicine-technology; Commissioned development of pharmaceutical preparations; Medical and scientific research, namely, conducting and evaluating clinical trials of pharmaceutical preparations for statutory approval; Assessment of scientific projects, namely, evaluating their feasibility, scientific value and costs; Assessment of clinical studies and clinical trials; medical, bacteriological and biochemical laboratory services for diagnosis, analysis, research and drug development in the field of medicine |
| Goods and Services | Services of a hospital; Services of medical practitioner; Services of a medical clinic; Pharmacy advice in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry, medicine-technology, health policy, business administration or related legal affairs; Medical assistance services; Nursing services; Medical sample testing services for samples provided by patients, volunteers, persons compelled by law, persons compelled by military institutions, persons compelled by educational institutions or employers to provide body samples for diagnostic purposes, treatment purposes and fitness evaluation |
| Pseudo Mark | MONDO RARE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, March 16, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, March 16, 2018 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, March 16, 2018 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, March 16, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, March 16, 2018 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | mondoBIOTECH Laboratories AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Vaduz FL-9490 LI |
| Party Name | mondoBIOTECH Laboratories AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Vaduz FL-9490 LI |
| Party Name | mondoBIOTECH Laboratories AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Vaduz FL-9490 LI |
| Event Date | Event Description |
| Friday, March 16, 2018 | CANCELLED SEC. 8 (6-YR) |
| Tuesday, August 9, 2011 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, May 24, 2011 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 24, 2011 | PUBLISHED FOR OPPOSITION |
| Thursday, April 21, 2011 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Tuesday, April 19, 2011 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, April 19, 2011 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, April 19, 2011 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, April 19, 2011 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, April 19, 2011 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, April 19, 2011 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Friday, April 15, 2011 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Saturday, April 2, 2011 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, April 1, 2011 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, March 11, 2011 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, March 10, 2011 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, March 10, 2011 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, March 10, 2011 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, October 8, 2010 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, October 8, 2010 | FINAL REFUSAL E-MAILED |
| Friday, October 8, 2010 | FINAL REFUSAL WRITTEN |
| Friday, September 17, 2010 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, September 17, 2010 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, September 17, 2010 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, March 23, 2010 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, March 23, 2010 | NON-FINAL ACTION E-MAILED |
| Tuesday, March 23, 2010 | NON-FINAL ACTION WRITTEN |
| Friday, February 26, 2010 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, February 26, 2010 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, February 26, 2010 | ASSIGNED TO LIE |
| Thursday, January 28, 2010 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, September 17, 2009 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, September 17, 2009 | NON-FINAL ACTION E-MAILED |
| Thursday, September 17, 2009 | NON-FINAL ACTION WRITTEN |
| Tuesday, August 25, 2009 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, August 25, 2009 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, August 25, 2009 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, May 8, 2009 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, May 8, 2009 | NON-FINAL ACTION E-MAILED |
| Friday, May 8, 2009 | NON-FINAL ACTION WRITTEN |
| Thursday, May 7, 2009 | ASSIGNED TO EXAMINER |
| Saturday, February 21, 2009 | NOTICE OF PSEUDO MARK MAILED |
| Friday, February 20, 2009 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, February 20, 2009 | NEW APPLICATION ENTERED IN TRAM |